Physician profile
Henry Goodwin
NPI 1265467286
$9,743.76
in general payments reported to CMS, 2019-2025
49 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $362 · 2021: $949 · 2022: $1,133 · 2023: $2,793 · 2024: $2,339 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,385 · Education: $53.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,385.00 |
| Education | $53.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $849.17 | 2023 | Prolaris |
| Axonics, INC. | $747.26 | 2021-2024 | Axonics |
| Astellas Pharma US INC | $698.44 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $681.78 | 2019-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $536.88 | 2020-2025 | |
| Procept Biorobotics Corporation | $508.98 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $463.16 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $447.12 | 2023-2024 | Urolift |
| Accord Healthcare, INC. | $427.94 | 2022-2025 | |
| Abbvie INC. | $426.27 | 2019-2025 | |
| Coloplast Corp | $393.84 | 2019-2025 | |
| Pfizer INC. | $367.01 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $307.02 | 2019-2024 | Provenge |
| Endo Pharmaceuticals INC. | $302.75 | 2019-2024 | Xiaflex, Aveed |
| Medtronic, INC. | $286.26 | 2024-2025 | Interstim |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $251.67 | 2024 | Adstiladrin |
| Boston Scientific Corporation | $194.52 | 2019-2025 | Axonics, Spaceoar System |
| Merck Sharp & Dohme LLC | $181.52 | 2020-2025 | Keytruda, Lynparza, Bridion |
| Myovant Sciences INC. | $178.35 | 2021-2022 | |
| Allergan, INC. | $151.26 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $109.79 | 2024 | Oxlumo |
| Neotract INC. | $109.13 | 2019 | |
| Cook Medical LLC | $96.36 | 2020 | |
| Verity Pharmaceuticals INC. | $89.15 | 2024-2025 | Trelstar |
| Urogen Pharma, INC. | $78.83 | 2022-2025 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $69.53 | 2022-2023 | Lynparza |
| Travere Therapeutics, INC. | $62.00 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $60.87 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Caldera Medical, INC | $55.62 | 2023 | Desara |
| Blue Earth Diagnostics | $50.94 | 2019-2024 | |
| Immunitybio, INC. | $49.57 | 2025 | |
| Progenics Pharmaceuticals, INC. | $48.82 | 2023-2025 | Pylarify |
| Novartis Pharmaceuticals Corporation | $46.93 | 2019-2023 | |
| Clarus Therapeutics INC. | $43.50 | 2021 | |
| Therapeuticsmd, INC. | $41.49 | 2019 | |
| Agiliti Surgical, INC. | $40.70 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu |
| C. R. Bard, INC. & Subsidiaries | $40.47 | 2022-2023 | Bard Urinary Drainage Bag |
| Antares Pharma, INC. | $39.28 | 2022-2023 | Tlando, Nocdurna, Xyosted |
| Endo USA, INC. | $31.36 | 2024 | Xiaflex |
| Innovation Technologies INC | $25.44 | 2025 | Irrisept |
| Tolmar, INC. | $21.68 | 2023 | |
| Ambu INC. | $19.62 | 2020-2022 | |
| Ethicon US, LLC | $18.37 | 2024 | Harmonic, Echelon Flex, Echelon Endopath |
| 180 Medical, INC. | $17.36 | 2025 | |
| Rochester Medical Corporation | $16.93 | 2019 | |
| Foundation Medicine, INC. | $16.57 | 2022 | |
| Smith+Nephew, INC. | $15.10 | 2022 | |
| Cardinal Health 414 LLC | $13.76 | 2023 | |
| Abbott Laboratories | $13.39 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.